BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29777455)

  • 1. Combined Preoperative ALBI and FIB-4 Is Associated with Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
    Liao R; Li DW; Du CY; Li M
    J Gastrointest Surg; 2018 Oct; 22(10):1679-1687. PubMed ID: 29777455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
    Zhang J; Luo Y; Li C; Liu J; Xiang H; Wen T
    Biosci Trends; 2019; 13(4):351-357. PubMed ID: 31527331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.
    Liao R; Peng C; Li M; Li DW; Jiang N; Li PZ; Ding X; Wu Q; Du CY; Gong JP
    Cancer Med; 2018 Apr; 7(4):1170-1182. PubMed ID: 29533004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
    Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
    Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
    Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
    [No Abstract]   [Full Text] [Related]  

  • 7. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
    Luo H; Li C; Chen L
    Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of albumin-bilirubin grade and clinically significant portal hypertension predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
    Qin L; Li C; Xie F; Wang Z; Wen T
    Biosci Trends; 2021 Mar; 15(1):41-49. PubMed ID: 33627573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ALBI Grade is a Good Predictive Model for Very Late Recurrence in Patients with Hepatocellular Carcinoma Undergoing Primary Resection.
    Lin CY; Lin CC; Wang CC; Chen CL; Hu TH; Hung CH; Huang PY; Tsai MC
    World J Surg; 2020 Jan; 44(1):247-257. PubMed ID: 31559485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DGPRI, a new liver fibrosis assessment index, predicts recurrence of AFP-negative hepatocellular carcinoma after hepatic resection: a single-center retrospective study.
    Zhang B; Xue J; Xu B; Chang J; Li X; Huang Z; Zhao H; Cai J
    Sci Rep; 2024 May; 14(1):10726. PubMed ID: 38730095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A
    Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
    Ho SY; Hsu CY; Liu PH; Hsia CY; Su CW; Huang YH; Hou MC; Huo TI
    Eur J Surg Oncol; 2019 May; 45(5):776-781. PubMed ID: 30401507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection.
    Huang J; Liu FC; Li L; Zhou WP; Jiang BG; Pan ZY
    Cancer Med; 2020 Apr; 9(8):2791-2802. PubMed ID: 32096346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Child-Pugh grade
    Huang F; Gao J
    World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FIB-4 index is a significant prognostic factor in patients with non-B non-C hepatocellular carcinoma after curative surgery.
    Okamura Y; Ashida R; Yamamoto Y; Ito T; Sugiura T; Bekku E; Aramaki T; Uesaka K
    Langenbecks Arch Surg; 2016 Mar; 401(2):195-203. PubMed ID: 26943655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
    Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBV-DNA Load-Related Peritumoral Inflammation and ALBI Scores Predict HBV Associated Hepatocellular Carcinoma Prognosis after Curative Resection.
    Liao R; Du CY; Gong JP; Luo F
    J Oncol; 2018; 2018():9289421. PubMed ID: 30327670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy.
    Wang ZX; Peng W; Zhang XY; Wen TF; Li C
    Medicine (Baltimore); 2021 Mar; 100(11):e24476. PubMed ID: 33725934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of the FIB-4 index for non-B non-C hepatocellular carcinoma treated with surgical resection.
    Nishikawa H; Osaki Y; Komekado H; Sakamoto A; Saito S; Nishijima N; Nasu A; Arimoto A; Kita R; Kimura T
    Oncol Rep; 2015 Jan; 33(1):88-94. PubMed ID: 25354477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of preoperative albumin-bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma.
    Kornberg A; Witt U; Schernhammer M; Kornberg J; Müller K; Friess H; Thrum K
    J Surg Oncol; 2019 Dec; 120(7):1126-1136. PubMed ID: 31578753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.